212.23
+6.97
+(3.40%)
At close: April 9 at 7:08:22 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 16 | 16 |
| Avg. Estimate | 2.73B | 3.19B | 12.05B | 13.17B |
| Low Estimate | 2.66B | 3.13B | 11.71B | 12.82B |
| High Estimate | 2.78B | 3.26B | 12.21B | 13.6B |
| Year Ago Sales | 2.57B | 2.95B | 11.17B | 12.05B |
| Sales Growth (year/est) | 5.92% | 7.97% | 7.88% | 9.30% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0J5I.L | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Jefferies: Hold to Hold | 4/9/2025 |
| Maintains | Truist Securities: Hold to Hold | 3/21/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/4/2025 |
| Maintains | Susquehanna: Neutral to Neutral | 2/25/2025 |
| Maintains | Raymond James: Outperform to Outperform | 2/10/2025 |
| Maintains | Macquarie: Neutral to Neutral | 2/7/2025 |